UBS AG has revised its price target for Brenntag SE, lowering it to 80 euros from 85 euros, but maintaining a "Buy" rating.

The revision was prompted by a lack of near-term growth acceleration in the industrial and business services segment, leading to a significant downward adjustment in estimates for the chemicals trader.

Despite the reduced price target, Brenntag's shares are still considered to be undervalued, suggesting potential for future investment interest.

The analysis was published on October 18, 2024, as part of a sector study and reflects the ongoing challenges in the market.